DNMT3A and acute myeloid leukemia: It has long been known that the primary leukemogenic mutations are usually epigenetic modifiers (TET2, DNMT3A, IDH1/2, ASXL1, because they are part of the PRC1/PRC2 circuit), followed by NPM1 or RAS mutations that eventually lead to AML progression [24].